Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $46.8 million.

  • MDxHealth's Cash & Current Investments fell 502.11% to $46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.8 million, marking a year-over-year decrease of 502.11%. This contributed to the annual value of $46.8 million for FY2024, which is 10910.63% up from last year.
  • MDxHealth's Cash & Current Investments amounted to $46.8 million in Q3 2025, which was down 502.11% from $262.0 billion recorded in Q2 2025.
  • MDxHealth's 5-year Cash & Current Investments high stood at $262.0 billion for Q2 2025, and its period low was $14.5 million during Q1 2024.
  • For the 5-year period, MDxHealth's Cash & Current Investments averaged around $16.4 billion, with its median value being $46.8 million (2024).
  • As far as peak fluctuations go, MDxHealth's Cash & Current Investments tumbled by 7349.82% in 2022, and later surged by 122722383.81% in 2025.
  • MDxHealth's Cash & Current Investments (Quarter) stood at $58.5 million in 2021, then plummeted by 73.5% to $15.5 million in 2022, then surged by 44.36% to $22.4 million in 2023, then soared by 109.11% to $46.8 million in 2024, then changed by 0.0% to $46.8 million in 2025.
  • Its last three reported values are $46.8 million in Q3 2025, $262.0 billion for Q2 2025, and $65.7 million during Q1 2025.